We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

104 hedge funds and large institutions have $650M invested in Mirum Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 25 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

206% more call options, than puts

Call options by funds: $422K | Put options by funds: $138K

88% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 25

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

3% less capital invested

Capital invested by funds: $673M → $650M (-$23.1M)

2.76% less ownership

Funds ownership: 93.18% → 90.42% (-2.8%)

7% less funds holding

Funds holding: 112 → 104 (-8)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

Holders
104
Holders Change
-8
Holders Change %
-7.14%
% of All Funds
1.67%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
16
Increased
47
Reduced
25
Closed
23
Calls
$422K
Puts
$138K
Net Calls
+$284K
Net Calls Change
-$80K

Top Buyers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
+$15.5M
2
State Street
State Street
Massachusetts
+$15.2M
3
TCM
Tang Capital Management
California
+$13.2M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.55M
5
BlackRock
BlackRock
New York
+$7.66M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$22.4M
2
CCM
Cadian Capital Management
New York
-$19.5M
3
Victory Capital Management
Victory Capital Management
Texas
-$14.6M
4
FLAM
First Light Asset Management
Minnesota
-$11M
5
PCH
Polar Capital Holdings
United Kingdom
-$6.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$3.65M +$2.63M +133,139 +245%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$3.41M -$403K -20,397 -10%
Citigroup
28
Citigroup
New York
$3.27M +$581K +29,407 +21%
Wellington Management Group
29
Wellington Management Group
Massachusetts
$3.02M -$212K -10,746 -6%
Rafferty Asset Management
30
Rafferty Asset Management
New York
$2.85M +$1.73M +87,697 +150%
HP
31
Highlander Partners
Texas
$2.4M – – –
SCM
32
Stonepine Capital Management
Oregon
$2.12M +$2.15M +108,769 New
UBS Group
33
UBS Group
Switzerland
$2.09M +$1.76M +89,139 +496%
LPC
34
Lion Point Capital
New York
$2.07M +$336K +17,000 +21%
OCA
35
Octagon Capital Advisors
New York
$1.95M – – –
Renaissance Technologies
36
Renaissance Technologies
New York
$1.82M +$1.84M +93,300 New
Two Sigma Advisers
37
Two Sigma Advisers
New York
$1.56M -$635K -32,100 -29%
JP Morgan Chase
38
JP Morgan Chase
New York
$1.53M +$1.27M +64,388 +454%
Morgan Stanley
39
Morgan Stanley
New York
$1.52M -$333K -16,846 -18%
N
40
Nuveen
North Carolina
$1.43M -$207K -10,497 -13%
IBT
41
International Biotechnology Trust
United Kingdom
$1.31M +$1.15M +58,281 +632%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$1.28M +$93.6K +4,737 +8%
PAI
43
Palo Alto Investors
California
$1.26M – – –
Deutsche Bank
44
Deutsche Bank
Germany
$1.15M +$1.01M +51,123 +638%
CP
45
CenterBook Partners
Connecticut
$1.06M +$1.08M +54,464 New
PHP
46
Parkman Healthcare Partners
Connecticut
$1.03M +$205K +10,359 +24%
Charles Schwab
47
Charles Schwab
California
$1.01M +$28.3K +1,430 +3%
SSA
48
Schonfeld Strategic Advisors
New York
$971K +$104K +5,262 +12%
Swiss National Bank
49
Swiss National Bank
Switzerland
$938K +$21.7K +1,100 +2%
RJFSA
50
Raymond James Financial Services Advisors
Florida
$921K -$59.8K -3,025 -6%
1
2
3 4 5

MIRM Hedge Fund Activity: Q4 2022 in Review

104 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q4 2022, worth a combined $650M — down 3.4% from $673M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of MIRM and 16 opened new positions — a net loss of 7 holders — while 25 trimmed existing stakes and 47 added.

The largest buyer was Eventide Asset Management, adding an estimated $15.5M. The largest seller was Franklin Resources, cutting an estimated $22.4M.

  • 104 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q4 2022, down from 112 in Q3 2022.
  • Funds reported $650M of Mirum Pharmaceuticals stock for Q4 2022, down 3.4% quarter-over-quarter.
  • 16 funds opened new Mirum Pharmaceuticals positions in Q4 2022 and 23 closed out, a net change of -7 holders.
  • The largest Mirum Pharmaceuticals buyer in Q4 2022 was Eventide Asset Management, an estimated $15.5M added.
  • The largest Mirum Pharmaceuticals seller in Q4 2022 was Franklin Resources, an estimated $22.4M sold.

Based on aggregated 13F filings for Q4 2022.